Covered recipient · General Payments record
ANA ASENCIO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$968.57
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $320.85 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $154.66 | 8 |
| Novo Nordisk AS | $101.98 | 1 |
| Evofem Biosciences, Inc. | $42.02 | 2 |
| Organon LLC | $22.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $14.73 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139474348 | CMS |
| Astellas Pharma US Inc | $24.22 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139491046 | CMS |
| Astellas Pharma US Inc | $21.12 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139493186 | CMS |
| Astellas Pharma US Inc | $17.97 | 05/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139503007 | CMS |
| Astellas Pharma US Inc | $19.43 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139465178 | CMS |
| Astellas Pharma US Inc | $17.68 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139528164 | CMS |
| Astellas Pharma US Inc | $19.09 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139538622 | CMS |
| Astellas Pharma US Inc | $20.42 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139552627 | CMS |
| Evofem Biosciences, Inc. | $23.07 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091287973 | CMS |
| Evofem Biosciences, Inc. | $18.95 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091287968 | CMS |
| Novo Nordisk Inc | $101.98 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100548662 | CMS |
| Organon Llc | $22.19 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136238314 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.